Dr. Chelsey Ann Petz, MD

Dr. Petz practices at CHI Alegent Health Physical Therapy Clinic Bergan - Unit in Omaha, Nebraska.

Dr. Petz's NPI, 1700014677, was assigned on June 30, 2009. Dr. Petz graduated from Creighton University School of Medicine in 2009. Dr. Petz holds South Carolina license 32005.

Dr. Petz's primary practice is CHI Alegent Health Physical Therapy Clinic Bergan - Unit, at 7710 Mercy Rd, Omaha, NE 68124.

Dr. Petz's primary practice is CHI Alegent Health Physical Therapy Clinic Bergan - Unit in Omaha, Nebraska. Dr. Petz is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Petz to 4 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Petz's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petz practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Petz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Petz's licenses on file in 2 states: South Carolina and Ohio.

CMS data shows 481 Medicare services from Dr. Petz across 5 procedure codes in 2024, for 191 Medicare patients. Medicare paid $22,135 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Petz in 2024. The largest group is 65 to 74, with 102 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Petz's median patient age at 65, with 63% women.

In 2024, Dr. Petz wrote 2,743 Medicare Part D claims for 456 patients. 82% of them were for generic drugs. CMS names the drug for 2,097 of them, across 64 drugs with 11 or more claims each, at $279,339 in total drug cost. In 2023, CMS named 1,531 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Petz for performance year 2024, reported as part of a group. Dr. Petz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Petz, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Hydroxymethylglutaryl-CoA Reductase Inhibitors, Liver Cirrhosis and Non-alcoholic Fatty Liver Disease. Dr. Petz has published most often in J Investig Med High Impact Case Rep. Dr. Petz's most frequent co-authors are Andrew D. Schreiner, MD, William P. Moran, MD and Don C. Rockey, MD.

CMS Open Payments shows 11 general payments to Dr. Petz from 7 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Radius Health, Inc. paid the most, $61.

Dr. Petz graduated from Creighton University School of Medicine in 2009.